Log in
APRINOIA Therapeutics
Contact
Links
Previous companies
View in org chart
Mark S. Shearman
CEO
Lana Gladstein
Group General Counsel And Interim Chief Operations Officer
Masaomi Miyamoto
EVP of R&D & Operations
Tzu-Chen Yen
General Manager
Lili Zhang
SVP, Head of Preclinical Development
+ 4 more
May, 2023 - present